Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
6
|
| pubmed:dateCreated |
1981-9-25
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Jun
|
| pubmed:issn |
0305-7453
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
7
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
629-35
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:6265427-Bacteria,
pubmed-meshheading:6265427-Blood,
pubmed-meshheading:6265427-Cefotaxime,
pubmed-meshheading:6265427-Cephalosporins,
pubmed-meshheading:6265427-Cephamycins,
pubmed-meshheading:6265427-Humans,
pubmed-meshheading:6265427-Microbial Sensitivity Tests,
pubmed-meshheading:6265427-Moxalactam
|
| pubmed:year |
1981
|
| pubmed:articleTitle |
Comparative in-vitro activity of moxalactam and cefotaxime against isolates from blood culture.
|
| pubmed:publicationType |
Journal Article,
Comparative Study
|